FDA Approves Non-Opioid Non-Addictive Painkiller Suzetrigine This approval paves the way for a widely anticipated rollout amid mixed opinions among physician

The FDA has approved suzetrigine, the first non-opioid non-addictive painkiller in a new class. It treats acute to moderate pain by blocking pain signals peripherally. A Phase 3 trial for chronic pain is ongoing. HCPs recognize potential in new drug.
#MedComms #GoodNewsPharma #Pharma #DrugLaunch